Long Focus Capital Management, LLC - REATA PHARMACEUTICALS INC ownership

REATA PHARMACEUTICALS INC's ticker is RETA and the CUSIP is 75615P103. A total of 149 filers reported holding REATA PHARMACEUTICALS INC in Q2 2022. The put-call ratio across all filers is 0.53 and the average weighting 0.3%.

Quarter-by-quarter ownership
Long Focus Capital Management, LLC ownership history of REATA PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2022$251,000
-64.1%
10,000
-56.5%
0.02%
-67.1%
Q2 2022$699,000
-7.2%
23,0000.0%0.07%
-24.7%
Q1 2022$753,000
-40.5%
23,000
-52.1%
0.10%
-42.3%
Q4 2021$1,266,00048,0000.17%
Other shareholders
REATA PHARMACEUTICALS INC shareholders Q2 2022
NameSharesValueWeighting ↓
CPMG Inc 2,896,901$94,902,00015.92%
Opaleye Management Inc. 407,002$13,333,0004.14%
Ikarian Capital, LLC 649,600$21,281,0002.80%
AWH Capital, L.P. 150,000$2,459,4572.54%
Boxer Capital, LLC 1,239,000$40,590,0002.09%
EcoR1 Capital, LLC 1,975,611$64,721,0002.02%
Camber Capital Management LP 1,500,000$49,140,0001.78%
MPM BioImpact LLC 180,000$5,897,0001.58%
Sofinnova Investments, Inc. 602,545$19,739,0001.50%
KRS Capital Management, LLC 28,141$921,0001.00%
View complete list of REATA PHARMACEUTICALS INC shareholders